Proteomics International Laboratories Ltd Price Chart
Proteomics International Laboratories Ltd PIQ.XA Financial and Trading Overview
Contents
- Proteomics International Laboratories Ltd Price Chart
- Proteomics International Laboratories Ltd PIQ.XA Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Proteomics International Laboratories Ltd
- Q&A For Proteomics International Laboratories Ltd Stock
| Proteomics International Laboratories Ltd stock price | 0.99 AUD |
| Previous Close | 0.83 AUD |
| Open | 0.76 AUD |
| Bid | 0.82 AUD x N/A |
| Ask | 0 AUD x N/A |
| Day's Range | 0.75 - 0.83 AUD |
| 52 Week Range | 0.62 - 1.16 AUD |
| Volume | 31.63K AUD |
| Avg. Volume | 10.06K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.039 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PIQ.XA Valuation Measures
| Enterprise Value | 87.02M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 11.148648 |
| Enterprise Value/Revenue | 26.203 |
| Enterprise Value/EBITDA | -15.276 |
Trading Information
Proteomics International Laboratories Ltd Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 1.16 AUD |
| 52 Week Low | 0.62 AUD |
| 50-Day Moving Average | 0.88 AUD |
| 200-Day Moving Average | 0.94 AUD |
PIQ.XA Share Statistics
| Avg. Volume (3 month) | 10.06K AUD |
| Avg. Daily Volume (10-Days) | 11.36K AUD |
| Shares Outstanding | N/A |
| Float | 74.72M |
| Short Ratio | N/A |
| % Held by Insiders | 34.90% |
| % Held by Institutions | 0.67% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2023 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | June 30, 2024 |
Profitability
| Profit Margin | -185.99% |
| Operating Margin (ttm) | -187.47% |
| Gross Margin | 29.37% |
| EBITDA Margin | -171.52% |
Management Effectiveness
| Return on Assets (ttm) | -50.29% |
| Return on Equity (ttm) | -106.41% |
Income Statement
| Revenue (ttm) | 3.32M AUD |
| Revenue Per Share (ttm) | 0.03 AUD |
| Quarterly Revenue Growth (yoy) | -8.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -5696245 AUD |
| Net Income Avi to Common (ttm) | -6176573 AUD |
| Diluted EPS (ttm) | -0.039 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.03M AUD |
| Total Cash Per Share (mrq) | 0.05 AUD |
| Total Debt (mrq) | 64.09K AUD |
| Total Debt/Equity (mrq) | 0.77 AUD |
| Current Ratio (mrq) | 7.551 |
| Book Value Per Share (mrq) | 0.074 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5692911 AUD |
| Levered Free Cash Flow (ttm) | -4933440 AUD |
Profile of Proteomics International Laboratories Ltd
| Country | Australia |
| State | WA |
| City | Perth |
| Address | QEII Medical Centre |
| ZIP | 6009 |
| Phone | 61 8 9389 1992 |
| Website | https://www.proteomics.com.au |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.
Q&A For Proteomics International Laboratories Ltd Stock
What is a current PIQ.XA stock price?
Proteomics International Laboratories Ltd PIQ.XA stock price today per share is 0.99 AUD.
How to purchase Proteomics International Laboratories Ltd stock?
You can buy PIQ.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Proteomics International Laboratories Ltd?
The stock symbol or ticker of Proteomics International Laboratories Ltd is PIQ.XA.
How many shares does Proteomics International Laboratories Ltd have in circulation?
The max supply of Proteomics International Laboratories Ltd shares is 0.
What is Proteomics International Laboratories Ltd Price to Earnings Ratio (PE Ratio)?
Proteomics International Laboratories Ltd PE Ratio is now.
What was Proteomics International Laboratories Ltd earnings per share over the trailing 12 months (TTM)?
Proteomics International Laboratories Ltd EPS is -0.039 AUD over the trailing 12 months.